लोड हो रहा है...
Ibrutinib Therapy and Mycobacterium chelonae Skin and Soft Tissue Infection
Ibrutinib is an irreversible inhibitor of Bruton’s tyrosine kinase approved for the treatment of B-cell malignancies. There is growing concern about the risk of opportunistic infections following ibrutinib therapy. Herein, we describe the first case of Mycobacterium chelonae skin and soft tissue inf...
में बचाया:
| में प्रकाशित: | Open Forum Infect Dis |
|---|---|
| मुख्य लेखकों: | , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Oxford University Press
2018
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6065501/ https://ncbi.nlm.nih.gov/pubmed/30090839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy168 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|